Funder
National Health and Medical Research Council of Australia
Canadian Insitutes of Health Research
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference26 articles.
1. Moore TJ, Singh S, Furberg CD. The FDA and new safety warnings. Arch Intern Med. 2012;172:78–80. https://doi.org/10.1001/archinternmed.2011.618.
2. McAdams M, Staffa J, Dal Pan G. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis. Pharmacoepidemiol Drug Saf. 2008;17:229–39. https://doi.org/10.1002/pds.1535.
3. Moore TJ, Bennett CL. Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the US Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012;38:905–7. https://doi.org/10.1055/s-0032-1328890.
4. Tau N, Shochat T, Gafter-Gvili A, et al. Association between data sources and US Food and Drug Administration Drug Safety Communications. JAMA Intern Med. 2019. https://doi.org/10.1001/jamainternmed.2019.3066(Published Online First: 3 September 2019).
5. FDA Adverse Events Reporting System (FAERS) : Latest Quarterly Data Files. Food Drug Adm. Web Site. 2019. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm082193.htm. Accessed 7 Nov 2019.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献